These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15209414)

  • 1. Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm.
    Mohrenweiser HW
    Toxicol Pathol; 2004; 32 Suppl 1():136-45. PubMed ID: 15209414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using biomarkers of genetic susceptibility to enhance the study of cancer etiology.
    Rothman N; Hayes RB
    Environ Health Perspect; 1995 Nov; 103 Suppl 8(Suppl 8):291-5. PubMed ID: 8741801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of new technologies on human population studies.
    Waters MD; Selkirk JK; Olden K
    Mutat Res; 2003 Nov; 544(2-3):349-60. PubMed ID: 14644337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes.
    Mohrenweiser HW; Wilson DM; Jones IM
    Mutat Res; 2003 May; 526(1-2):93-125. PubMed ID: 12714187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?
    Mohrenweiser HW; Jones IM
    Mutat Res; 1998 May; 400(1-2):15-24. PubMed ID: 9685572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamic epigenome and its implications in toxicology.
    Szyf M
    Toxicol Sci; 2007 Nov; 100(1):7-23. PubMed ID: 17675334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems Toxicology: The Future of Risk Assessment.
    Sauer JM; Hartung T; Leist M; Knudsen TB; Hoeng J; Hayes AW
    Int J Toxicol; 2015; 34(4):346-8. PubMed ID: 25804424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in toxicology.
    Timbrell JA
    Toxicology; 1998 Aug; 129(1):1-12. PubMed ID: 9769106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic factors in toxicology: implications for toxicological screening.
    Festing MF
    Crit Rev Toxicol; 1987; 18(1):1-26. PubMed ID: 3311639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges to environmental toxicology and epidemiology: where do we stand and which way do we go?
    Pesch B; Brüning T; Frentzel-Beyme R; Johnen G; Harth V; Hoffmann W; Ko Y; Ranft U; Traugott UG; Thier R; Taeger D; Bolt HM
    Toxicol Lett; 2004 Jun; 151(1):255-66. PubMed ID: 15177661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk and the complexity of the interactions between environmental and host factors: HENVINET interactive diagrams as simple tools for exploring and understanding the scientific evidence.
    Merlo DF; Filiberti R; Kobernus M; Bartonova A; Gamulin M; Ferencic Z; Dusinska M; Fucic A
    Environ Health; 2012 Jun; 11 Suppl 1(Suppl 1):S9. PubMed ID: 22759509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic polymorphism and risk of diseases induced by chemicals].
    Zhang Z; Xia Z
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):402-5. PubMed ID: 14535113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans.
    Mohrenweiser HW; Xi T; Vázquez-Matías J; Jones IM
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1054-64. PubMed ID: 12376507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxicogenomics. New perspectives for the molecular toxicology].
    Lutz W; Kur B
    Med Pr; 2004; 55(2):193-202. PubMed ID: 15524089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.